Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 70,034 |
| TOTAL | $70,087 |
| Non-Current Assets | |
| TOTAL | $N/A |
| Total Assets | $70,087 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 7 |
| Accrued Expenses | 99 |
| TOTAL | $411 |
| Non-Current Liabilities | |
| Deferred Revenues | 142 |
| Other Non-Current Liabilities | 13,579 |
| TOTAL | $13,579 |
| Total Liabilities | $13,989 |
| Shareholders' Equity | |
| Shares Outstanding, K | 39 |
| Common Shares | 1 |
| Other shareholders' equity | 277 |
| TOTAL | $56,097 |
| Total Liabilities And Equity | $70,087 |